Navigation Links
FDA Accepts Genta's NDA Amendment as Complete Response for Genasense(R) Treatment of Chronic Lymphocytic Leukemia
Date:7/14/2008

Submission Based on Increased 5-Year Survival in Responding Patients

BERKELEY HEIGHTS, N.J., July 14 /PRNewswire-FirstCall/ -- Genta Incorporated (OTC Bulletin Board: GNTA) announced that the Food and Drug Administration (FDA) has accepted the Company's amendment to its New Drug Application (NDA) for Genasense(R) (oblimersen sodium) Injection as a "complete response". The NDA proposed the use of Genasense plus chemotherapy for patients with relapsed or refractory chronic lymphocytic leukemia (CLL). The recent submission was based on new information from the Company's completed, randomized Phase 3 trial that showed, among other findings, a significant increase in overall survival for patients who achieved a complete or partial response when treated with Genasense plus chemotherapy compared with patients treated with chemotherapy alone.

The amendment responds to a communication received in March 2008 from FDA's Center for Drug Evaluation and Research (CDER) that denied Genta's appeal of a prior "non-approvable" decision of the Genasense NDA in December 2006. That communication described a regulatory path forward that included but was not limited to determination of long-term survival in patients who entered the study. FDA has informed the Company that it considers Genta's complete response as a Class 2 resubmission with a Prescription Drug User Fee Act (PDUFA) goal date of December 3, 2008.

"We are pleased that the FDA will formally review this new information, and we look forward to working with FDA's Division of Oncology Drug Products during their consideration of this amendment," commented Dr. Loretta M. Itri, Genta's President, Pharmaceutical Development, and Chief Medical Officer.

About Chronic Lymphocytic Leukemia

CLL is the most common form of leukemia in adults. According to the American Cancer Society, approximately 8,000 patients will be diagnosed this year. More than 60,000 people in the U.S. currently have CLL. The
'/>"/>

SOURCE Genta Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Partnering With MyPyramid: NUTRIKIDS Accepts the Challenge to Help Families Step Up to Healthier Living
2. AMEX Accepts Lorus Plan to Meet AMEXs Continued Listing Standards
3. Mike Huckabee Accepts Values Voter Presidential Debate
4. ev3 Inc. Accepts Resignation of Dr. John Simpson
5. Lieutenant Governor Catherine Baker Knoll Accepts Women in Government Presidential Leadership Award
6. FDA Accepts New Drug Application for NEBIDO(R) Submitted by Indevus
7. Governor Rendell Accepts National Health Care Reform Pioneer Award
8. American Stock Exchange Accepts Encisions Plan to Regain Compliance
9. FDA Accepts New Drug Application for Priority Review of Investigational HIV Treatment TMC125
10. FDA Accepts New Drug Application for Priority Review of Investigational HIV Treatment TMC125
11. Nuvo Research and Paladin announce amendments to Pennsaid and Pennsaid Plus agreements
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2014)... substantial proportion of risk for developing autism spectrum disorders ... interconnected biological pathways, according to researchers from the Icahn ... broad study of almost 2,500 families in the United ... "Convergence of Genes and Cellular Pathways Dysregulated in Autism ... American Journal of Human Genetics on April 24. ...
(Date:4/24/2014)... Scientific research at UT Southwestern Medical Center previously ... completely, whereas the adult heart lacks this ability. New ... the heart loses its incredible regenerative capability in adulthood, ... , Yes, oxygen. It is well-known that a major ... throughout the body. But at the same time, oxygen ...
(Date:4/24/2014)... Changes in managing patients before, during and after colorectal ... readmission rates, according to researchers who led a study ... practice, called enhanced recovery, is easier on patients before ... evacuation that are typically prescribed. After surgery, patients are ... possible, leading to faster recoveries. , Among findings published ...
(Date:4/24/2014)... terminology, and the relevance of palliation in advanced ... randomized controlled trials (RCTs). This is the result ... Quality and Efficiency in Health Care (IQWiG), which ... Together with external experts, IQWiG analysed studies on ... malignant melanoma, and pancreatic cancer. For this purpose, ...
(Date:4/24/2014)... A Finnish team of researchers was the first in ... which is a tumour of the jaw. , Ameloblastoma ... recur after treatment. Ameloblastoma is most often found in ... by surgery, often resulting in tissue deficiencies in the ... suitable drug therapy could reduce the need for surgery ...
Breaking Medicine News(10 mins):Health News:Genetic alterations in shared biological pathways as major risk factor for ASD 2Health News:Oxygen diminishes the heart's ability to regenerate, researchers discover 2Health News:New approach for surgery patients cuts hospital stays and costs 2Health News:New approach for surgery patients cuts hospital stays and costs 3Health News:Palliation is rarely a topic in studies on advanced cancer 2Health News:Palliation is rarely a topic in studies on advanced cancer 3
... Their growths also tend to be on the right side, requiring ... -- Among Hispanics, men are twice as likely as women to ... polyps, a new study in Puerto Rico has found. , The ... 56 percent more likely to have polyps than those younger than ...
... ... endometriosis, diagnosis and treatment options. , ... (PRWEB) May 2, 2010 -- The Endometriosis Foundation of America (EFA) ... Science of Endometriosis: Stem Cells to Radical Excision Surgery”, taking place in New York ...
... VANCOUVER, BRITISH COLUMBIA Reports have suggested that sleep ... (ASDs) are associated with challenging daytime behaviors. ... with ASD confirms these reports and will support the ... to improve behavior, according to researchers from Autism Speaks, ...
... ask children to fast overnight before a cholesterol test. New ... "Cholesterol testing can be very difficult for families," said Asheley ... presented Sunday, May 2 at the Pediatric Academic Societies (PAS) ... fast, this almost always means the child has to return ...
... majority of teens say they have never heard of acetaminophen ... with access to the label instructions despite having taken ... Medical Center Study assessing teens, health literacy. More than 60 ... heard of acetaminophen despite 21 percent of them having taken ...
... include Tylenol, Tylenol Plus, Motrin and Benadryl , SATURDAY, ... Friday recalled more than 40 of its liquid cold ... medications may not meet federal quality standards. , The ... Plus, Motrin, Zyrtec and Benadryl. These medications have been ...
Cached Medicine News:Health News:Colon Polyps More Common in Hispanic Men Than Women 2Health News:Endometriosis Foundation of America to Present Landmark Scientific Symposium in NYC 2Health News:Children may be able to eat before cholesterol test, study shows 2
(Date:1/15/2014)... Jan. 15, 2014  Research and Markets ( http://www.researchandmarkets.com/research/6k27gw/dental ) ... Market - Global Industry Analysis, Size, Share, Growth, Trends ... offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ... used on patients in order to treat dental impairments, ...
(Date:1/15/2014)... Texas , Jan. 15, 2014  Novation, the leading ... awarded several new IT value-added reseller (VAR) national contracts ... IT goods and services at lower costs. These include ... services such as initiative assistance and ongoing IT consulting ...
(Date:1/15/2014)... DUBLIN , January 15, 2014 Shire plc ... waived the Office of Fair Trading (OFT) approval condition to the ... Incorporated (NASDAQ: VPHM).   As a result of the ... Shire expects to complete the tender offer on January 24, 2014 ...
Breaking Medicine Technology:Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 2Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 3New Novation Information Technology VAR Contracts Offer Significant Savings to Hospitals 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 3
...   Sysmex America, Inc., a global leader in medical ... its 200th placement of Sysmex WAM ™ ... WAM is now connecting nearly 600 sites and approximately ... Canada. Sysmex WAM plays a key role in delivering ...
... March 20, 2012   A new Consumer Reports poll shows ... The poll was released just as House and Senate ... governing medical devices and at a time when the ... intense criticism.  The House Energy and ...
Cached Medicine Technology:Sysmex America Achieves Clinical Laboratory Connectivity Milestone 2Consumer Reports Poll: Americans Overwhelmingly Support Strong Medical Device Safety Oversight 2Consumer Reports Poll: Americans Overwhelmingly Support Strong Medical Device Safety Oversight 3Consumer Reports Poll: Americans Overwhelmingly Support Strong Medical Device Safety Oversight 4
... Our variable volume Finnpipette ... in a high performance pipette. ... colour-coded volume range, ensures quality, ... identification of the volume range ...
A Biplane Pediatric TEE transducer....
Super High Density, multi-frequency, convex array transducer for scanning during craniotomies. Same footprint as the UST-987-7.5 but with stronger penetration for deep cavernous tumors and other deep...
... Super High Density, multi-frequency, linear ... the first company to introduce ... and, as a result, changed ... and true workhorse has withstood ...
Medicine Products: